AVACEN (Advanced Vascular Circulation Enhancement) Medical® is a leading provider of drug-free, noninvasive treatments for pain relief and management, wellness, as well as diagnostics for cardiovascular disease and stress. Our heat therapy systems for pain relief were developed while working with research scientists at a leading university. They are FDA Cleared Class II medical devices indicated for: (1) minor muscle pain (2) joint pain and stiffness (3) joint pain associated with arthritis (4) muscle spasms (5) minor strains and sprains (6) muscle relaxation, and (7) temporary increase of local circulation.
Headquarters: Carlsbad, CA
Devices Field Tested: >10,000
Treatments: >25 million
Patents: 17 U.S. & International
Regulatory: FDA Cleared Class II medical devices
Awards & Recognition
"The patented AVACEN® Treatment Method is an entirely new concept in chronic pain treatment through muscular relaxation..."
The AVACEN® Treatment Method bathes the skeletal muscles with warm oxygenated and nutritious blood. Overall, our process increases microcirculation. The main functions of microcirculation are to deliver oxygen and nutrients while removing carbon dioxide and wastes. Microcirculation also serves to regulate tissue blood flow. This affects blood pressure and responses to inflammation, including edema (swelling), and chronic pain associated with numerous medical afflictions such as CRPS, Lyme Disease, Fibromyalgia, Rheumatoid Arthritis, Raynaud's Disease and Carpal Tunnel Syndrome.The Science Behind AVACEN®
AVACEN is Innovative and Effective.
Meet the Founders of AVACEN Medical - Thomas Muehlbauer and Danielle Forsgren launched the company to offer a new treatment modality to manage pain while improving wellness, via an innovative product design that offers pain and stress relief in the palm of your hand. AVACEN Medical is featured in popular industry journals like TOP DOCTOR Magazine (April, 2022).View AVACEN® Products
Meet Our Executives
Inventor / Founder / Chairman
Fortune 500 senior executive experience with over 40 Years of CEO and start up skills including acquisitions, capital formation and public market transitions. B.S. State University of New York.
CEO / President / Director
25 years of Fortune 500 and startup executive experience in sales, marketing, strategy and business development in medical devices, diagnostics, and HCIT. M.B.A. Boston University, M.A. Boston University School of Medicine, M.S. University of San Diego, B.A. Boston University.
Danielle J. Forsgren
CMO / Founder / Director
30+ years of sales and marketing experience. Coursework at International University and University of San Diego.
CCO / Chief Compliance Officer
Quality, Regulatory, and Operations leader with over 30 years of Fortune 500 and startup l experience in medical device/biotech. B.S. in Industrial Engineering from Iowa State University, is registered Professional Engineer in California, and has ASQ certifications for both Quality Engineering and Manager of Quality / Operational Excellence.
CFO / Chief Financial Officer
35+ years of experience in Finance focusing on business development, international trade, and business relations. Fortune 100 company and startup experience. B.A. University of Wyoming.
Vice President of Business Development
Bryon Moore has a diverse career spanning over 40 years in the Fire based and Emergency Medical Services Markets. Bryon ran clinical oversight for seven counties in Northern California for AMR before becoming entrenched in the development global sales and marketing of novel technologies such as eCPR and Non-Invasive ventilation.
Our board of Directors
Thomas G. Muehlbauer
Chairman / Founding Shareholder / AVACEN Inventor
Fortune 500 senior executive experience with over 25 years of CEO and startup skills including acquisitions, capital formation and public market transitions. Prior to founding AVACEN in 2009, Mr. Muehlbauer started an Internet company which was sold to a publicly traded company, bringing a return to founding investors of over 180% in 2 years. As a hands-on investor, he engineered the startup growth and sale of World View, International, providing multimillion dollar returns to shareholders in less than a three-year period.Mr. Muehlbauer developed his expertise in corporate management working for Fortune 500 companies. Management positions ranged from Worldwide Data Center Manager to President and CEO for three mid-sized corporations. He holds a Bachelor of Science from The State University of New York.
CEO / President / Director
25 years of Fortune 500 and startup executive experience in sales, marketing, strategy and business development in medical devices, diagnostics, and HCIT. Throughout his extensive career, Mr. Shimkin held key marketing and innovation leadership roles at several notable companies, including Qualcomm, where he served as senior director of marketing and later, senior director of business development. Before that, he held senior executive positions at Lantronix, Quidel, Cardinal Health, Alaris Medical Systems and Neoforma. He also led the health care equity research team at Wedbush Securities and consulted for leading life sciences companies including Abbott, Boston Scientific, Genentech, Roche and Sanofi. Anthony received his M.B.A. from Boston University, a M.A. from Boston University School of Medicine, a M.S. from the University of San Diego, and a B.A. from Boston University.
Danielle J. Forsgren
CMO / Director / Founder
Danielle has over 30 years of experience in sales and marketing. She has extensive theatre, radio, public speaking and TV experience including multiple appearances on QVC. As the Company’s top salesperson and Chief Marketing Officer, she is currently developing several strategic initiatives to globally expand sales. Her efforts of the last 3 years have placed the Company on the INC. 5000 list of fastest growing companies in the US. She studied at International University and the University of San Diego.
Director / Founding Shareholder
Jim’s former experience includes being a President and CEO, in addition to extensive engineering and engineering management experience. He was President and CEO of MAXIM Systems until the company was sold in December 2007 to Accenture. Prior to MAXIM, Mr. Wangler served as Chief Engineer for the ISR Directorate of SPAWAR Headquarters, where he also served as the Program Manager for a $200 million Space Surveillance program. He received his M.S. from San Diego State University.
Mr. Miller, a former Naval officer, was co-founder and Sr. V.P. of SeQual Technologies, a San Diego based medical device company. He was also an early-stage investor, Board member, and CFO for numerous companies in San Diego. He received his B.S. in Business Administration from the University of Kansas, and a M.S. in Finance from San Diego State University.
Fredrick P. Waid
Fred focuses primarily in the areas of trust and estate administration, real estate, banking, and corporate governance matters. He serves as a trustee, executor and special administrator of complex trusts and estates, by private and court appointment. Fred has been appointed by state and federal courts as a receiver, special servicer and interim corporate officer. He is a graduate of Baylor Law School and Brigham Young University.
Hamid currently acts as an executive consultant and advisor to various Fortune 100 companies and funded startups. He works closely with C-level leaders and board members focusing on lean manufacturing, strategic planning and effective leadership to help harvest a winning culture that’s conducive to reaching long-term KPIs. After working in a leadership role at Steelcase for over 20 years, he retired as Global Senior Vice President. During his time at Steelcase, he created and headed a project that reduced the company’s manufacturing footprint by 65% (9 million square feet), while increasing output by 200% and improving overall customer satisfaction.
Jonathan Lakey, Ph.D.
Dr. Lakey is currently a Professor Emeritus in Departments Surgery and Biomedical Engineering at University of California Irvine. Prior to his transition from Professor to Professor Emeritus, Dr. Lakey served as Director of Research and the Clinical Islet Program in the Department of Surgery, Director of the Department of Surgery Stem cell laboratory. He has received several awards for his achievements in transplantation research and sits on the Scientific Advisory Boards for several diabetes and biotechnology companies.
Pamela brings decades of experience at operational and executive levels for various medical device companies. She currently is COO for Panakeia, marketing products to the military health system. She served as Vice President of Operations at inventive Technologies, now owned by Philips, as well as a Senior Director for SeQual Technologies. She received her Bachelor of Science degree from the University of Massachusetts.
"My visit to AVACEN Medical was an exciting opportunity to honor a California-based small company that is making a big difference. During my visit, I used their FDA Cleared pain reduction product. I was surprised that besides being effective, it was so easy to operate."
The Honorable California State Treasurer Fiona Ma